{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:15:15Z","timestamp":1740107715771,"version":"3.37.3"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,1,6]],"date-time":"2024-01-06T00:00:00Z","timestamp":1704499200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,6]],"date-time":"2024-01-06T00:00:00Z","timestamp":1704499200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1007\/s10067-023-06851-x","type":"journal-article","created":{"date-parts":[[2024,1,6]],"date-time":"2024-01-06T01:05:57Z","timestamp":1704503157000},"page":"1111-1126","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Global trends in research of melanoma differentiation-associated gene 5: a bibliometric analysis from 2002 to 2022"],"prefix":"10.1007","volume":"43","author":[{"given":"Xueting","family":"Yuan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhao","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liying","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chanyuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiuliang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengtao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4541-9898","authenticated-orcid":false,"given":"Qian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaofeng","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,1,6]]},"reference":[{"key":"6851_CR1","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1073\/pnas.022637199","volume":"99","author":"DC Kang","year":"2002","unstructured":"Kang DC, Gopalkrishnan RV, Wu Q et al (2002) mda-5: an interferon-inducible putative RNA helicase with double-stranded RNA-dependent ATPase activity and melanoma growth-suppressive properties. Proc Natl Acad Sci USA 99:637\u2013642. https:\/\/doi.org\/10.1073\/pnas.022637199","journal-title":"Proc Natl Acad Sci USA"},{"key":"6851_CR2","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1038\/sj.onc.1207300","volume":"23","author":"DC Kang","year":"2004","unstructured":"Kang DC, Gopalkrishnan RV, Lin L et al (2004) Expression analysis and genomic characterization of human melanoma differentiation associated gene-5, mda-5: a novel type I interferon-responsive apoptosis-inducing gene. Oncogene 23:1789\u20131800. https:\/\/doi.org\/10.1038\/sj.onc.1207300","journal-title":"Oncogene"},{"key":"6851_CR3","doi-asserted-by":"publisher","first-page":"17264","DOI":"10.1073\/pnas.0407639101","volume":"101","author":"J Andrejeva","year":"2004","unstructured":"Andrejeva J, Childs KS, Young DF et al (2004) The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta promoter. Proc Natl Acad Sci USA 101:17264\u201317269. https:\/\/doi.org\/10.1073\/pnas.0407639101","journal-title":"Proc Natl Acad Sci USA"},{"key":"6851_CR4","doi-asserted-by":"publisher","first-page":"8459","DOI":"10.1073\/pnas.0603082103","volume":"103","author":"L Gitlin","year":"2006","unstructured":"Gitlin L, Barchet W, Gilfillan S et al (2006) Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus. Proc Natl Acad Sci USA 103:8459\u20138464. https:\/\/doi.org\/10.1073\/pnas.0603082103","journal-title":"Proc Natl Acad Sci USA"},{"key":"6851_CR5","doi-asserted-by":"publisher","first-page":"e1002341","DOI":"10.1371\/journal.pgen.1002341","volume":"7","author":"DS Cunninghame Graham","year":"2011","unstructured":"Cunninghame Graham DS, Morris DL, Bhangale TR et al (2011) Association of NCF2, IKZF1, IRF8, IFIH1, and TYK2 with systemic lupus erythematosus. PLoS Genet 7:e1002341. https:\/\/doi.org\/10.1371\/journal.pgen.1002341","journal-title":"PLoS Genet"},{"key":"6851_CR6","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/nri3850","volume":"15","author":"YJ Crow","year":"2015","unstructured":"Crow YJ, Manel N (2015) Aicardi-Goutieres syndrome and the type I interferonopathies. Nat Rev Immunol 15:429\u2013440. https:\/\/doi.org\/10.1038\/nri3850","journal-title":"Nat Rev Immunol"},{"key":"6851_CR7","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/ng1800","volume":"38","author":"DJ Smyth","year":"2006","unstructured":"Smyth DJ, Cooper JD, Bailey R et al (2006) A genome-wide association study of nonsynonymous SNPs identifies a type 1 diabetes locus in the interferon-induced helicase (IFIH1) region. Nat Genet 38:617\u2013619. https:\/\/doi.org\/10.1038\/ng1800","journal-title":"Nat Genet"},{"key":"6851_CR8","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.cell.2017.03.036","volume":"169","author":"KB Chiappinelli","year":"2017","unstructured":"Chiappinelli KB, Strissel PL, Desrichard A et al (2017) Inhibiting DNA methylation causes an interferon response in cancer via dsRNA including endogenous retroviruses. Cell 169:361. https:\/\/doi.org\/10.1016\/j.cell.2017.03.036","journal-title":"Cell"},{"key":"6851_CR9","doi-asserted-by":"publisher","first-page":"4428","DOI":"10.1093\/rheumatology\/keab224","volume":"60","author":"L Xu","year":"2021","unstructured":"Xu L, Wang L, Lv C et al (2021) Anti-MDA-5-positive dermatomyositis associated rapidly progressive interstitial lung disease, a virus-triggered autoimmune-like symptom? Rheumatology 60:4428\u20134429. https:\/\/doi.org\/10.1093\/rheumatology\/keab224","journal-title":"Rheumatology"},{"key":"6851_CR10","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1093\/rheumatology\/keab371","volume":"61","author":"T Gono","year":"2022","unstructured":"Gono T, Okazaki Y, Kuwana M (2022) Antiviral proinflammatory phenotype of monocytes in anti-MDA5 antibody-associated interstitial lung disease. Rheumatology (Oxford) 61:806\u2013814. https:\/\/doi.org\/10.1093\/rheumatology\/keab371","journal-title":"Rheumatology (Oxford)"},{"key":"6851_CR11","doi-asserted-by":"publisher","first-page":"939433","DOI":"10.3389\/fimmu.2022.939433","volume":"13","author":"F Wu","year":"2022","unstructured":"Wu F, Gao J, Kang J et al (2022) Knowledge mapping of exosomes in autoimmune diseases: a bibliometric analysis (2002-2021). Front Immunol 13:939433. https:\/\/doi.org\/10.3389\/fimmu.2022.939433","journal-title":"Front Immunol"},{"key":"6851_CR12","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2307\/2529310","volume":"33","author":"JR Landis","year":"1977","unstructured":"Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33:159\u2013174","journal-title":"Biometrics"},{"key":"6851_CR13","first-page":"724","volume":"2005","author":"MB Synnestvedt","year":"2005","unstructured":"Synnestvedt MB, Chen C, Holmes JH (2005) CiteSpace II: visualization and knowledge discovery in bibliographic databases. AMIA Annu Symp Proc 2005:724\u2013728","journal-title":"AMIA Annu Symp Proc"},{"key":"6851_CR14","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s11192-009-0146-3","volume":"84","author":"NJ van Eck","year":"2010","unstructured":"van Eck NJ, Waltman L (2010) Software survey: VOSviewer, a computer program for bibliometric mapping. Scientometrics 84:523\u2013538. https:\/\/doi.org\/10.1007\/s11192-009-0146-3","journal-title":"Scientometrics"},{"key":"6851_CR15","doi-asserted-by":"publisher","first-page":"8880","DOI":"10.1128\/JVI.00354-15","volume":"89","author":"R Hamel","year":"2015","unstructured":"Hamel R, Dejarnac O, Wichit S et al (2015) Biology of Zika virus infection in human skin cells. J Virol 89:8880\u20138896. https:\/\/doi.org\/10.1128\/JVI.00354-15","journal-title":"J Virol"},{"key":"6851_CR16","doi-asserted-by":"publisher","first-page":"3810","DOI":"10.1038\/s41467-020-17665-9","volume":"11","author":"X Lei","year":"2020","unstructured":"Lei X, Dong X, Ma R et al (2020) Activation and evasion of type I interferon responses by SARS-CoV-2. Nat Commun 11:3810. https:\/\/doi.org\/10.1038\/s41467-020-17665-9","journal-title":"Nat Commun"},{"key":"6851_CR17","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1007\/s10067-020-05190-5","volume":"39","author":"M Soy","year":"2020","unstructured":"Soy M, Keser G, Atagunduz P et al (2020) Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment. Clin Rheumatol 39:2085\u20132094. https:\/\/doi.org\/10.1007\/s10067-020-05190-5","journal-title":"Clin Rheumatol"},{"key":"6851_CR18","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1146\/annurev-immunol-032713-120156","volume":"32","author":"J Wu","year":"2014","unstructured":"Wu J, Chen ZJ (2014) Innate immune sensing and signaling of cytosolic nucleic acids. Annu Rev Immunol 32:461\u2013488. https:\/\/doi.org\/10.1146\/annurev-immunol-032713-120156","journal-title":"Annu Rev Immunol"},{"key":"6851_CR19","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1126\/science.aac7049","volume":"349","author":"BJ Liddicoat","year":"2015","unstructured":"Liddicoat BJ, Piskol R, Chalk AM et al (2015) RNA editing by ADAR1 prevents MDA5 sensing of endogenous dsRNA as nonself. Science 349:1115\u20131120. https:\/\/doi.org\/10.1126\/science.aac7049","journal-title":"Science"},{"key":"6851_CR20","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/nature13590","volume":"514","author":"D Goubau","year":"2014","unstructured":"Goubau D, Schlee M, Deddouche S et al (2014) Antiviral immunity via RIG-I-mediated recognition of RNA bearing 5\u2032-diphosphates. Nature 514:372\u2013375. https:\/\/doi.org\/10.1038\/nature13590","journal-title":"Nature"},{"key":"6851_CR21","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.coi.2014.12.012","volume":"32","author":"M Yoneyama","year":"2015","unstructured":"Yoneyama M, Onomoto K, Jogi M et al (2015) Viral RNA detection by RIG-I-like receptors. Curr Opin Immunol 32:48\u201353. https:\/\/doi.org\/10.1016\/j.coi.2014.12.012","journal-title":"Curr Opin Immunol"},{"issue":"72","key":"6851_CR22","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1146\/annurev-micro-102215-095605","volume":"72","author":"XJ Tan","year":"2018","unstructured":"Tan XJ, Sun LJ, Chen JQ et al (2018) Detection of microbial infections through innate immune sensing of nucleic acids. Annu Rev Microbiol 72(72):447\u2013478. https:\/\/doi.org\/10.1146\/annurev-micro-102215-095605","journal-title":"Annu Rev Microbiol"},{"key":"6851_CR23","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/j.cell.2015.07.056","volume":"162","author":"D Roulois","year":"2015","unstructured":"Roulois D, Loo Yau H, Singhania R et al (2015) DNA-demethylating agents target colorectal cancer cells by inducing viral mimicry by endogenous transcripts. Cell 162:961\u2013973. https:\/\/doi.org\/10.1016\/j.cell.2015.07.056","journal-title":"Cell"},{"key":"6851_CR24","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/s41586-018-0768-9","volume":"565","author":"JJ Ishizuka","year":"2019","unstructured":"Ishizuka JJ, Manguso RT, Cheruiyot CK et al (2019) Loss of ADAR1 in tumours overcomes resistance to immune checkpoint blockade. Nature 565:43\u201348. https:\/\/doi.org\/10.1038\/s41586-018-0768-9","journal-title":"Nature"},{"key":"6851_CR25","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nature04734","volume":"441","author":"H Kato","year":"2006","unstructured":"Kato H, Takeuchi O, Sato S et al (2006) Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441:101\u2013105. https:\/\/doi.org\/10.1038\/nature04734","journal-title":"Nature"},{"key":"6851_CR26","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1084\/jem.20080091","volume":"205","author":"H Kato","year":"2008","unstructured":"Kato H, Takeuchi O, Mikamo-Satoh E et al (2008) Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5. J Exp Med 205:1601\u20131610. https:\/\/doi.org\/10.1084\/jem.20080091","journal-title":"J Exp Med"},{"key":"6851_CR27","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1038\/ni1243","volume":"6","author":"T Kawai","year":"2005","unstructured":"Kawai T, Takahashi K, Sato S et al (2005) IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat Immunol 6:981\u2013988. https:\/\/doi.org\/10.1038\/ni1243","journal-title":"Nat Immunol"},{"key":"6851_CR28","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1038\/nature04193","volume":"437","author":"E Meylan","year":"2005","unstructured":"Meylan E, Curran J, Hofmann K et al (2005) Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437:1167\u20131172. https:\/\/doi.org\/10.1038\/nature04193","journal-title":"Nature"},{"key":"6851_CR29","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1126\/science.1132505","volume":"314","author":"V Hornung","year":"2006","unstructured":"Hornung V, Ellegast J, Kim S et al (2006) 5\u2032-Triphosphate RNA is the ligand for RIG-I. Science 314:994\u2013997. https:\/\/doi.org\/10.1126\/science.1132505","journal-title":"Science"},{"key":"6851_CR30","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/nature07725","volume":"458","author":"V Hornung","year":"2009","unstructured":"Hornung V, Ablasser A, Charrel-Dennis M et al (2009) AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature 458:514\u2013518. https:\/\/doi.org\/10.1038\/nature07725","journal-title":"Nature"},{"key":"6851_CR31","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1126\/science.1132998","volume":"314","author":"A Pichlmair","year":"2006","unstructured":"Pichlmair A, Schulz O, Tan CP et al (2006) RIG-I-mediated antiviral responses to single-stranded RNA bearing 5\u2032-phosphates. Science 314:997\u20131001. https:\/\/doi.org\/10.1126\/science.1132998","journal-title":"Science"},{"key":"6851_CR32","doi-asserted-by":"publisher","first-page":"2851","DOI":"10.4049\/jimmunol.175.5.2851","volume":"175","author":"M Yoneyama","year":"2005","unstructured":"Yoneyama M, Kikuchi M, Matsumoto K et al (2005) Shared and unique functions of the DExD\/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity. J Immunol 175:2851\u20132858. https:\/\/doi.org\/10.4049\/jimmunol.175.5.2851","journal-title":"J Immunol"},{"key":"6851_CR33","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature09907","volume":"472","author":"JW Schoggins","year":"2011","unstructured":"Schoggins JW, Wilson SJ, Panis M et al (2011) A diverse range of gene products are effectors of the type I interferon antiviral response. Nature 472:481\u2013485. https:\/\/doi.org\/10.1038\/nature09907","journal-title":"Nature"},{"key":"6851_CR34","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/j.immuni.2011.05.003","volume":"34","author":"YM Loo","year":"2011","unstructured":"Loo YM, Gale M Jr (2011) Immune signaling by RIG-I-like receptors. Immunity 34:680\u2013692. https:\/\/doi.org\/10.1016\/j.immuni.2011.05.003","journal-title":"Immunity"},{"key":"6851_CR35","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1023\/A:1024940629314","volume":"7","author":"J Kleinberg","year":"2003","unstructured":"Kleinberg J (2003) Bursty and hierarchical structure in streams. Data Min Knowl Discov 7:373\u2013397. https:\/\/doi.org\/10.1023\/A:1024940629314","journal-title":"Data Min Knowl Discov"},{"key":"6851_CR36","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.immuni.2005.04.010","volume":"23","author":"H Kato","year":"2005","unstructured":"Kato H, Sato S, Yoneyama M et al (2005) Cell type-specific involvement of RIG-I in antiviral response. Immunity 23:19\u201328. https:\/\/doi.org\/10.1016\/j.immuni.2005.04.010","journal-title":"Immunity"},{"key":"6851_CR37","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/ni1087","volume":"5","author":"M Yoneyama","year":"2004","unstructured":"Yoneyama M, Kikuchi M, Natsukawa T et al (2004) The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 5:730\u2013737. https:\/\/doi.org\/10.1038\/ni1087","journal-title":"Nat Immunol"},{"key":"6851_CR38","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/s41577-020-0288-3","volume":"20","author":"J Rehwinkel","year":"2020","unstructured":"Rehwinkel J, Gack MU (2020) RIG-I-like receptors: their regulation and roles in RNA sensing. Nat Rev Immunol 20:537\u2013551. https:\/\/doi.org\/10.1038\/s41577-020-0288-3","journal-title":"Nat Rev Immunol"},{"key":"6851_CR39","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1002\/art.41105","volume":"72","author":"H Tsuji","year":"2020","unstructured":"Tsuji H, Nakashima R, Hosono Y et al (2020) Multicenter prospective study of the efficacy and safety of combined immunosuppressive therapy with high-dose glucocorticoid, tacrolimus, and cyclophosphamide in interstitial lung diseases accompanied by anti-melanoma differentiation-associated gene 5-positive dermatomyositis. Arthritis Rheumatol 72:488\u2013498. https:\/\/doi.org\/10.1002\/art.41105","journal-title":"Arthritis Rheumatol"},{"key":"6851_CR40","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1002\/art.40320","volume":"69","author":"IE Lundberg","year":"2017","unstructured":"Lundberg IE, Tjarnlund A, Bottai M et al (2017) 2017 European League Against Rheumatism\/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Arthritis Rheumatol 69:2271\u20132282. https:\/\/doi.org\/10.1002\/art.40320","journal-title":"Arthritis Rheumatol"},{"key":"6851_CR41","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.tim.2018.08.007","volume":"27","author":"AG Dias Junior","year":"2019","unstructured":"Dias Junior AG, Sampaio NG, Rehwinkel J (2019) A balancing act: MDA5 in antiviral immunity and autoinflammation. Trends Microbiol 27:75\u201385. https:\/\/doi.org\/10.1016\/j.tim.2018.08.007","journal-title":"Trends Microbiol"},{"key":"6851_CR42","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.cell.2012.11.048","volume":"152","author":"B Wu","year":"2013","unstructured":"Wu B, Peisley A, Richards C et al (2013) Structural basis for dsRNA recognition, filament formation, and antiviral signal activation by MDA5. Cell 152:276\u2013289. https:\/\/doi.org\/10.1016\/j.cell.2012.11.048","journal-title":"Cell"},{"key":"6851_CR43","doi-asserted-by":"publisher","first-page":"10761","DOI":"10.1128\/JVI.00770-09","volume":"83","author":"A Pichlmair","year":"2009","unstructured":"Pichlmair A, Schulz O, Tan CP et al (2009) Activation of MDA5 requires higher-order RNA structures generated during virus infection. J Virol 83:10761\u201310769. https:\/\/doi.org\/10.1128\/JVI.00770-09","journal-title":"J Virol"},{"key":"6851_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2478\/rir-2022-0001","volume":"3","author":"F Halilu","year":"2022","unstructured":"Halilu F, Christopher-Stine L (2022) Myositis-specific antibodies: overview and clinical utilization. Rheumatol Immunol Res 3:1\u201310. https:\/\/doi.org\/10.2478\/rir-2022-0001","journal-title":"Rheumatol Immunol Res"},{"key":"6851_CR45","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/s41572-021-00321-x","volume":"7","author":"IE Lundberg","year":"2021","unstructured":"Lundberg IE, Fujimoto M, Vencovsky J et al (2021) Idiopathic inflammatory myopathies. Nat Rev Dis Primers 7:86. https:\/\/doi.org\/10.1038\/s41572-021-00321-x","journal-title":"Nat Rev Dis Primers"},{"key":"6851_CR46","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1002\/art.21023","volume":"52","author":"S Sato","year":"2005","unstructured":"Sato S, Hirakata M, Kuwana M et al (2005) Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis. Arthritis Rheum 52:1571\u20131576. https:\/\/doi.org\/10.1002\/art.21023","journal-title":"Arthritis Rheum"},{"key":"6851_CR47","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1111\/tan.13171","volume":"90","author":"JM Lin","year":"2017","unstructured":"Lin JM, Zhang YB, Peng QL et al (2017) Genetic association of HLA-DRB1 multiple polymorphisms with dermatomyositis in Chinese population. Hla 90:354\u2013359. https:\/\/doi.org\/10.1111\/tan.13171","journal-title":"Hla"},{"key":"6851_CR48","doi-asserted-by":"publisher","first-page":"3736","DOI":"10.1002\/art.34657","volume":"64","author":"T Gono","year":"2012","unstructured":"Gono T, Kawaguchi Y, Kuwana M et al (2012) Brief report: association of HLA-DRB1*0101\/*0405 with susceptibility to anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis in the Japanese population. Arthritis Rheum 64:3736\u20133740. https:\/\/doi.org\/10.1002\/art.34657","journal-title":"Arthritis Rheum"},{"key":"6851_CR49","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1136\/annrheumdis-2017-212149","volume":"77","author":"Y Kochi","year":"2018","unstructured":"Kochi Y, Kamatani Y, Kondo Y et al (2018) Splicing variant of WDFY4 augments MDA5 signalling and the risk of clinically amyopathic dermatomyositis. Ann Rheum Dis 77:602\u2013611. https:\/\/doi.org\/10.1136\/annrheumdis-2017-212149","journal-title":"Ann Rheum Dis"},{"key":"6851_CR50","doi-asserted-by":"publisher","unstructured":"Theisen DJ, Davidson JT, Briseno CG et al (2018) WDFY4 is required for cross-presentation in response to viral and tumor antigens. Science 362:694-+. https:\/\/doi.org\/10.1126\/science.aat5030","DOI":"10.1126\/science.aat5030"},{"key":"6851_CR51","doi-asserted-by":"publisher","unstructured":"Nishina N, Sato S, Masui K et al (2020) Seasonal and residential clustering at disease onset of anti-MDA5-associated interstitial lung disease. RMD Open 6. https:\/\/doi.org\/10.1136\/rmdopen-2020-001202","DOI":"10.1136\/rmdopen-2020-001202"},{"key":"6851_CR52","doi-asserted-by":"publisher","first-page":"833114","DOI":"10.3389\/fmed.2021.833114","volume":"8","author":"H Hu","year":"2021","unstructured":"Hu H, Yang H, Liu Y et al (2021) Pathogenesis of anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis: a concise review with an emphasis on type I interferon system. Front Med (Lausanne) 8:833114. https:\/\/doi.org\/10.3389\/fmed.2021.833114","journal-title":"Front Med (Lausanne)"},{"key":"6851_CR53","doi-asserted-by":"publisher","first-page":"151","DOI":"10.55563\/clinexprheumatol\/ubov8b","volume":"39","author":"C He","year":"2021","unstructured":"He C, Chen J, Luo X et al (2021) Evaluation of biomarkers related to endothelial dysfunction: proof of vasculopathy in anti-melanoma differentiation-associated gene 5 dermatomyositis. Clin Exp Rheumatol 39:151\u2013157. https:\/\/doi.org\/10.55563\/clinexprheumatol\/ubov8b","journal-title":"Clin Exp Rheumatol"},{"key":"6851_CR54","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1111\/j.1365-2230.2006.02150.x","volume":"31","author":"J Wenzel","year":"2006","unstructured":"Wenzel J, Schmidt R, Proelss J et al (2006) Type I interferon-associated skin recruitment of CXCR3+ lymphocytes in dermatomyositis. Clin Exp Dermatol 31:576\u2013582. https:\/\/doi.org\/10.1111\/j.1365-2230.2006.02150.x","journal-title":"Clin Exp Dermatol"},{"key":"6851_CR55","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1016\/j.rmed.2015.07.004","volume":"109","author":"T Takada","year":"2015","unstructured":"Takada T, Aoki A, Asakawa K et al (2015) Serum cytokine profiles of patients with interstitial lung disease associated with anti-CADM-140\/MDA5 antibody positive amyopathic dermatomyositis. Respir Med 109:1174\u20131180. https:\/\/doi.org\/10.1016\/j.rmed.2015.07.004","journal-title":"Respir Med"},{"key":"6851_CR56","doi-asserted-by":"publisher","first-page":"16833","DOI":"10.1038\/s41598-017-17007-8","volume":"7","author":"Y Ishida","year":"2017","unstructured":"Ishida Y, Kimura A, Nosaka M et al (2017) Essential involvement of the CX3CL1-CX3CR1 axis in bleomycin-induced pulmonary fibrosis via regulation of fibrocyte and M2 macrophage migration. Sci Rep 7:16833. https:\/\/doi.org\/10.1038\/s41598-017-17007-8","journal-title":"Sci Rep"},{"key":"6851_CR57","doi-asserted-by":"publisher","first-page":"e192","DOI":"10.1136\/annrheumdis-2020-218594","volume":"81","author":"Y Wang","year":"2022","unstructured":"Wang Y, Du G, Zhang G et al (2022) Similarities and differences between severe COVID-19 pneumonia and anti-MDA-5-positive dermatomyositis-associated rapidly progressive interstitial lung diseases: a challenge for the future. Ann Rheum Dis 81:e192. https:\/\/doi.org\/10.1136\/annrheumdis-2020-218594","journal-title":"Ann Rheum Dis"},{"key":"6851_CR58","doi-asserted-by":"publisher","first-page":"e28686","DOI":"10.1002\/jmv.28686","volume":"95","author":"D Bojkova","year":"2023","unstructured":"Bojkova D, Bechtel M, Rothenburger T et al (2023) Omicron-induced interferon signaling prevents influenza A H1N1 and H5N1 virus infection. J Med Virol 95:e28686. https:\/\/doi.org\/10.1002\/jmv.28686","journal-title":"J Med Virol"},{"key":"6851_CR59","doi-asserted-by":"publisher","first-page":"791348","DOI":"10.3389\/fimmu.2021.791348","volume":"12","author":"G Wang","year":"2021","unstructured":"Wang G, Wang Q, Wang Y et al (2021) Presence of anti-MDA5 antibody and its value for the clinical assessment in patients with COVID-19: a retrospective cohort study. Front Immunol 12:791348. https:\/\/doi.org\/10.3389\/fimmu.2021.791348","journal-title":"Front Immunol"},{"key":"6851_CR60","doi-asserted-by":"publisher","first-page":"102831","DOI":"10.1016\/j.jaut.2022.102831","volume":"130","author":"F Coutant","year":"2022","unstructured":"Coutant F, Bachet R, Pin JJ et al (2022) Monoclonal antibodies from B cells of patients with anti-MDA5 antibody-positive dermatomyositis directly stimulate interferon gamma production. J Autoimmun 130:102831. https:\/\/doi.org\/10.1016\/j.jaut.2022.102831","journal-title":"J Autoimmun"},{"key":"6851_CR61","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1186\/s13075-018-1737-2","volume":"20","author":"Y Ishikawa","year":"2018","unstructured":"Ishikawa Y, Iwata S, Hanami K et al (2018) Relevance of interferon-gamma in pathogenesis of life-threatening rapidly progressive interstitial lung disease in patients with dermatomyositis. Arthritis Res Ther 20:240. https:\/\/doi.org\/10.1186\/s13075-018-1737-2","journal-title":"Arthritis Res Ther"},{"key":"6851_CR62","doi-asserted-by":"publisher","first-page":"e70","DOI":"10.1212\/WNL.0000000000009727","volume":"95","author":"Y Allenbach","year":"2020","unstructured":"Allenbach Y, Uzunhan Y, Toquet S et al (2020) Different phenotypes in dermatomyositis associated with anti-MDA5 antibody: study of 121 cases. Neurology 95:e70\u2013ee8. https:\/\/doi.org\/10.1212\/WNL.0000000000009727","journal-title":"Neurology"},{"key":"6851_CR63","doi-asserted-by":"publisher","first-page":"808875","DOI":"10.3389\/fmed.2021.808875","volume":"8","author":"X Lv","year":"2021","unstructured":"Lv X, Jin Y, Zhang D et al (2021) Low circulating monocytes is in parallel with lymphopenia which predicts poor outcome in anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis-associated interstitial lung disease. Front Med (Lausanne) 8:808875. https:\/\/doi.org\/10.3389\/fmed.2021.808875","journal-title":"Front Med (Lausanne)"},{"key":"6851_CR64","doi-asserted-by":"publisher","first-page":"768052","DOI":"10.3389\/fmed.2021.768052","volume":"8","author":"W Xu","year":"2021","unstructured":"Xu W, Wu W, Zheng Y et al (2021) A computed tomography radiomics-based prediction model on interstitial lung disease in anti-MDA5-positive dermatomyositis. Front Med (Lausanne) 8:768052. https:\/\/doi.org\/10.3389\/fmed.2021.768052","journal-title":"Front Med (Lausanne)"},{"key":"6851_CR65","doi-asserted-by":"publisher","first-page":"860798","DOI":"10.3389\/fmed.2022.860798","volume":"9","author":"ZM Ouyang","year":"2022","unstructured":"Ouyang ZM, Lin JZ, Tang AJ et al (2022) A matrix prediction model for the 6-month mortality risk in patients with anti-melanoma differentiation-associated protein-5-positive dermatomyositis. Front Med (Lausanne) 9:860798. https:\/\/doi.org\/10.3389\/fmed.2022.860798","journal-title":"Front Med (Lausanne)"},{"key":"6851_CR66","doi-asserted-by":"publisher","unstructured":"Ida T, Furuta S, Takayama A et al (2023) Efficacy and safety of dose escalation of tofacitinib in refractory anti-MDA5 antibody-positive dermatomyositis. RMD Open 9. https:\/\/doi.org\/10.1136\/rmdopen-2022-002795","DOI":"10.1136\/rmdopen-2022-002795"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-023-06851-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-023-06851-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-023-06851-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,22]],"date-time":"2024-02-22T11:12:54Z","timestamp":1708600374000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-023-06851-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,6]]},"references-count":66,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["6851"],"URL":"https:\/\/doi.org\/10.1007\/s10067-023-06851-x","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"type":"print","value":"0770-3198"},{"type":"electronic","value":"1434-9949"}],"subject":[],"published":{"date-parts":[[2024,1,6]]},"assertion":[{"value":"19 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"This study did not include patients as participants in the research; therefore, ethical approval was not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}